论文部分内容阅读
据中国医药工业公司今年5月召开的全国化学原料药计划座谈会消息,45个主要药品的内、外销形势是: 1.产量增加、内外销均好:青霉素G—K,青霉素G—Na,氨苄青霉素,庆大霉素,土霉素盐,吡哝酸,布洛芬,扑热息痛,VC、VE,左旋咪唑,硫糖铝,咖啡因,灭滴灵,红霉素,痢特灵。 2.产量增加,内外销上升,但价格下降:洁霉素,土霉素。 3.产量增加,内销仍上升:麦迪霉素。 4.产量增加,出口增长,内销稳定:烟酸,烟酰胺。 5.产量增加,出口增加:氨苄矾,金
According to the symposium of the National Chemical API Program held by China Pharmaceutical Industry Corporation in May this year, the situation of domestic and overseas sales of 45 major pharmaceutical products is as follows: 1. Output increased with good export and domestic sales: penicillin G-K, penicillin G-Na, Ampicillin, gentamicin, oxytetracycline, picolinic acid, ibuprofen, paracetamol, VC, VE, levamisole, sucralfate, caffeine, metronidazole, erythromycin, furazolidone. 2. Production increased, the export rise, but the price drop: lincomycin, oxytetracycline. 3. Output increased, the domestic sales are still rising: midecamycin. 4. Output increase, export growth, domestic sales stability: niacin, nicotinamide. 5. Production increased, exports increased: alum, gold